Home » Consortium Headed by Enigma Dx Receives $2.3M to Develop TB Assay

Consortium Headed by Enigma Dx Receives $2.3M to Develop TB Assay

Mar 11, 2014
|
staff reporter

NEW YORK (GenomeWeb News) – Enigma Diagnostics today announced a second grant from the UK's Technology Strategy Board to further develop the company's multidrug-resistant tuberculosis (MDR-TB) test on its Enigma Mini Laboratory system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

The Apple's Journey

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

This Week in Nature

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Change Is Hard to Do

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

Possible Paths for CUP

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.

What's Popular?

In PCR

  1. Single-Color Digital PCR Method Shows Promise for Blood-Based Cancer Monitoring

    Premium

  2. Heart Disease Risk Alleles Reported In 17th Century Korean Mummy

  3. Myriad Genetics' Breast Cancer Recurrence Test Wins Positive Coverage From Palmetto, Anthem

  4. FDA Grants EUA for Columbia University's Zika Test

  5. Curetis Posts 9 Percent Drop in H1 Revenues

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.